Zobrazeno 1 - 10
of 363
pro vyhledávání: '"R, Saral"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
E F, Winton, J, Srinivasiah, B K, Kim, C D, Hillyer, E A, Strobert, J L, Orkin, R B, Swenson, H M, McClure, L A, Myers, R, Saral
Publikováno v:
Blood. 84:65-73
Using a recently developed hepsulfam-induced pancytopenia model in rhesus macaques, we have studied the effects of recombinant human interleukin-6 (rhIL-6) and rhIL-3 on marrow regeneration. Control animals were given hepsulfam (1.5 g/m2 by a single
Autor:
J E, Wagner, G W, Santos, S J, Noga, S D, Rowley, J, Davis, G B, Vogelsang, E R, Farmer, B A, Zehnbauer, R, Saral, A D, Donnenberg
Publikováno v:
Blood. 75:1370-1377
In an attempt to reduce the incidence and severity of acute graft- versus-host disease (GVHD), we have decreased the number of bone marrow (BM) lymphocytes in the donor marrow graft before bone marrow transplantation (BMT) using counterflow centrifug
Autor:
Joseph W. Fay, G. Herzig, John H. Kersey, Elizabeth J. Shpall, Frederick R. Appelbaum, E. Petersdorf, J. Wolf, R. Parkman, D. Przepiorka, R. Saral
Publikováno v:
Biology of Blood and Marrow Transplantation. 7(10)
Biol Blood Marrow Transplant 2001;7(10):577.
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 20:635-637
Early analyses of the effects of “accidental” Total Body Irradiation (TBI) led to the discovery of the possibilities of bone marrow transplantation (4-6). The logical consequence of these new insights was the design of treatment protocols in whic
Autor:
J W, Fay, J R, Wingard, J H, Antin, R H, Collins, L A, Piñeiro, B R, Blazar, R, Saral, B E, Bierer, D, Przepiorka, W E, Fitzsimmons, R M, Maher, D J, Weisdorf
Publikováno v:
Blood. 87(8)
FK506 (Tacrolimus) is an immunosuppressive drug that blocks the activation of antigen-specific T lymphocytes, a major component in the pathogenesis of graft-versus-host disease (GVHD). This study was designed to obtain first estimates of the safety a
Autor:
S P, Dix, J R, Wingard, R E, Mullins, I, Jerkunica, T G, Davidson, C E, Gilmore, R C, York, L S, Lin, S M, Devine, R B, Geller, L T, Heffner, C D, Hillyer, H K, Holland, E F, Winton, R, Saral
Publikováno v:
Bone marrow transplantation. 17(2)
Busulfan pharmacokinetics, specifically area under the concentration curve (AUC), have been correlated with the occurrence of veno-occlusive disease (VOD) following BMT. To evaluate the risk of VOD, we studied 66 patients who received pharmacotherape
Autor:
F, Appelbaum, J, Fay, G, Herzig, J, Kersey, R, Parkman, E, Petersdorf, D, Przepiorka, R, Saral, E, Shpall, J, Wolf
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 1(1)
Publikováno v:
Seminars in oncology. 20(4 Suppl 4)
Preparative regimens used prior to bone marrow transplantation (BMT) in patients with malignancies must mediate engraftment and eradicate malignant cells without producing significant extramedullary toxicities. The first agents to be tested in BMT pr
Autor:
R. Saral
Publikováno v:
Infectious Complications in Bone Marrow Transplantation ISBN: 9783642849015
Herpes simplex infections may cause significant morbidity following bone marrow transplantation (BMT) (Saral 1988). The pathophysiology of these infections was studied in the pre-antiviral era and provided the basis for the development of studies des
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d25a8b64c289644b9d7f65293e0e8606
https://doi.org/10.1007/978-3-642-84899-5_16
https://doi.org/10.1007/978-3-642-84899-5_16